Skip to content

Analysis of the efficacy of duloxetine and pregabalin for analgesia after total knee arthroplasty: a prospective, randomized controlled study

Analysis of the efficacy of duloxetine and pregabalin for analgesia after total knee arthroplasty: a prospective, randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079841
Enrollment
Unknown
Registered
2024-01-15
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of the knee

Interventions

Duloxetine group:Oral duloxetine 60 mg/dose once daily beginning two days before surgery and continuing through 14 days postoperatively
Pregabalin group:Oral pregabalin 150 mg/dose twice daily beginning two days before surgery and continuing through 14 days postoperatively
drug combination group:Oral duloxetine 60 mg/dose once a day and oral pregabalin 150 mg/dose twice a day starting two days prior to surgery and continuing until 14 days postoperatively
control group:After the 6h postoperative fasting period, oral erixib tablets 0.1g, codeine 500mg, starting on the second postoperative day and up to 14 days postoperatively, oral erixib tablets 0.1g/d

Sponsors

Honghui Hospital, Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Eligible for surgical indications, with diagnostic findings of osteoarthritis of the knee through clinical and imaging tests; 2 Subjects in the study were adult patients, aged 50-80 years, scheduled to undergo primary TKA; 3 American Society of Anesthesiologists (ASA) assessment classification of 1-3; 4 No contraindications to medication; 5 Patients agreed to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1 Patients with a history of hepatic or renal unhealthiness, severe cardiopulmonary disease, severe gastrointestinal disease, or psychiatric disease; 2 Patients who are allergic or intolerant to duloxetine, pregabalin or anesthetic drugs; 3 Patients taking duloxetine, pregabalin, or opioids within 2 weeks before surgery; 4 Patients with mental illness and cognitive impairment; 5 Patients with previous open surgery on the same side of the knee.

Design outcomes

Primary

MeasureTime frame
Visual analog scores;keen society score;

Secondary

MeasureTime frame
SF-36;Knee range of motion;Opioid consumption;length of stay;

Countries

China

Contacts

Public ContactWu Haodong; Huang Yuanchi

Honghui Hospital, Xi'an Jiaotong University

Huangychell@163.com+86 180 9297 0326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026